FP496
Non Member
Dr.Naresh Babu
| Membership No | Author Name | Mobile | |
|---|---|---|---|
| 3127 | Dr.Ashish R Manthalkar | ashishmanthalkar@gmail.com | 9538585070 |
Medical Retina
Healing the Hole: The Promise of Platelet-Rich Plasma
Purpose : To compare the safety and efficacy of 25 gauge pars plana vitrectomy (PPV) with platelet rich plasma (PRP) for the treatment of macular hole. Methods: Pseudophakic patients with idiopathic macular holes with a minimum diameter (MD) of 600–1500 µm were selected (n=30 patients. All underwent 25 gauge PPV with PRP (group B). Results: Mean MD was 784.73 ± 120.10 µm, (P = 0.552). Mean base diameter was 1486.90 ± 281.61 µm (P = 0.180). The median presenting best corrected visual acuity (BCVA) was logMAR 0.78 (Range 0.60–1.00) (P = 0.103). Anatomical closure was achieved in 93.3% (n = 28/30) (P = 0.158). Type 1 closure was achieved in 83.3% (n = 25/30) eyes.Median BCVA at postoperative 3 month was logMAR 0.60 (range 0.48–0.78), (P = 0.312). The average visual improvement was 2.5 early treatment diabetic retinopathy study (ETDRS) lines (P = 0.339). None of the patients developed postoperative exaggerated inflammatory reactions. Conclusion: “PRP may transform macular hole surgery from simply closing a defect to biologically promoting healing.”
No Co-Author Selected